Oligomerization of dopamine and serotonin receptors

Neuropsychopharmacology

Volumn 23, Issue 4, 2000, Pages S32-S40

  Lee, Samuel P ^a   Xie, Zhidong ^a   Varghese, George ^a   Nguyen, Tuan ^b   O'dowd, Brian F ^a,b   George, Susan R ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Agonists; Dimerization; Dopamine receptors; G protein coupled receptor; Oligomerization; Serotonin receptors

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR;

DIMERIZATION; DISULFIDE BOND; DOPAMINERGIC SYSTEM; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; SEROTONINERGIC SYSTEM; STRUCTURE ACTIVITY RELATION;

ANIMAL; DIMERIZATION; DOPAMINE AGONISTS; GTP-BINDING PROTEINS; HUMAN; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; SUPPORT, NON-U.S. GOV'T;

EID: 0033796939     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00155-X     Document Type: Article

References (43)

1. Barnes NM, Sharp T (1999): A review of central 5-HT recep-tors and their function. Neuropharmacology 38:1083-1152
2. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT (1997): Mechanism of transdominant inhibition of CCR5-medi-ated HIV-1 infection by ccr5A32. J Biol Chem 272:30603-30606
3. Bonaventure P, Voorn P, Luyten WH, Jurzak M, Schotte A, Leysen JE (1998): Detailed mapping of serotonin 5-HT1Band 5-HT1D receptor messenger RNA and ligand bind-ing sites in guinea-pig brain and trigeminal ganglion:Clues for function. Neuroscience 82:469-484
4. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991): Localization of dopamine D3 recep-tor mRNA in the rat brain using in situ hybridizationhistochemistry: Comparison with dopamine D2 recep-tor mRNA. Brain Res 564:203-219
5. Cvejic S, Devi LA (1997): Dimerization of the delta opioid receptor: Implication for a role in receptor internaliza-tion. J Biol Chem 272:26959-26964
6. Elmhurst JL, Xie Z, O'Dowd BF, George SR (2000): The splice variant D3nf reduces ligand binding to the D3dopamine receptor: evidence for heterooligomerization.Mol Brain Res (In press)
7. Fan GF, Ray K, Zhao XM, Goldsmith PK, Spiegel AM (1998):Mutational analysis of the cysteines in the extracellular domain of the human Ca2+receptor: Effects on cell sur-face expression, dimerization and signal transduction.FEBS Lett 436:353-356
8. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GY, O'Dowd BF (1998): A transmembrane domain-derived peptide inhibits D1 dopamine receptor functionwithout affecting receptor oligomerization. J Biol Chem273:30244-30248
9. Gouldson PR, Snell CR, Reynolds CA (1997): A new approach to docking in the ß2-adrenergic receptor thatexploits the domain structure of G protein-coupledreceptors. J Med Chem 40:3871-3886
10. Grigoriadis DE, Niznik HB, Jarvie KR, Seeman P (1988): Gly-coprotein nature of D2 dopamine receptors. FEBS Lett 227:220-224
11. Grosse R, Schoneberg T, Schultz G, Gudermann T (1997): Inhibition of gonadotropin-releasing hormone receptorsignaling by expression of a splice variant of the humanreceptor. Mol Endocrinol 11:1305-1318
12. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Bar-ret C, Bouvier M (1996): A peptide derived from a beta2-adrenergic receptor transmembrane domaininhibits both receptor dimerization and activation. J BiolChem 271:16384-16392
13. Jacobs S, Moxham C (1991): Hybrid receptors. New Biol 3:110-115
14. Jarvis DL (1997): Baculovirus expression vectors. In Miller LK (ed), The Baculoviruses (The Viruses). New York, Plenum Press, pp 389-431
15. Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AM, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'DowdBF (1992): Characterization of the human 5-hydroxy-tryptamine1B receptor. J Biol Chem 267:5735-5738
16. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, (1998): GABA(B) receptors function as a heteromericassembly of the subunits GABA(B)R1 and GABA(B)R2.Nature 396:674-679
17. Jordan BA, Devi LA (1999): G protein-coupled receptor het-erodimerization modulates receptor function. Nature 399:697-700
18. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, (1998): GABA(B)-receptor sub-types assemble into functional heteromeric complexes.Nature 396:683-687
19. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A, Kornau HC (1999): Role of heteromer formation in gAbAB receptor function. Science 283:74-77
20. Lee SP, O'Dowd BF, Ng GY, Varghese G, Akil H, Mansour A, Nguyen T, George SR (2000): Inhibition of cell sur-face expression by mutant receptors demonstrates thatD2 dopamine receptors exist as oligomers in the cell.Mol Pharmacol 58:120-128
21. Liu K, Bergson C, Levenson R, Schmauss C (1994): On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immu-noreactivity in human brain. J Biol Chem 269:29220-29226
22. Marshall FH, Jones KA, Kaupmann K, Bettler B (1999): GABAB receptors-the first 7TM heterodimers. TrendsPharmacol Sci 20:396-399
23. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998): Dopamine receptors: From structure to function.Physiol Rev 78:189-225
24. Ng GY, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, (1999): Identification ofa GABAB receptor subunit, gb2, required for functionalGABAB receptor activity. J Biol Chem 274:7607-7610
25. Ng GY, George SR, Zastawny RL, Caron M, Bouvier M, Dennis M, O'Dowd BF (1993): Human serotonin1Breceptor expression in Sf cells: phosphorylation, palm-itoylation, and adenylyl cyclase inhibition. Biochemistry 32:11727-11733
26. Ng GY, Mouillac B, George SR, Caron M, Dennis M, Bouvier M, O'Dowd BF (1994a): Desensitization, phosphoryla-tion and palmitoylation of the human dopamine D1receptor. Eur J Pharmacol 267:7-19
27. Ng GY, O'Dowd BF, Caron M, Dennis M, Brann MR, George SR (1994b): Phosphorylation and palmitoylation of thehuman D2L dopamine receptor in Sf9 cells. J Neuro-chem 63:1589-1595
28. Ng GY, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P, George SR (1996): Dopamine D2 receptor dimers andreceptor-blocking peptides. Biochem Biophys Res Com-mun 227:200-204
29. Ng GY, Trogadis J, Stevens J, Bouvier M, O'Dowd BF, George SR (1995): Agonist-induced desensitization ofdopamine D1 receptor-stimulated adenylyl cyclaseactivity is temporally and biochemically separated fromD1 receptor internalization. Proc Natl Acad Sci USA92:10157-10161
30. Ng GY, Varghese G, Chung HT, Trogadis J, Seeman P, O'Dowd BF, George SR (1997): Resistance of thedopamine D2L receptor to desensitization accompaniesthe up-regulation of receptors on to the surface of Sf9cells. Endocrinology 138:4199-4206
31. Nimchinsky EA, Hof PR, Janssen WG, Morrison JH, Schmauss C (1997): Expression of dopamine D3 receptor dimers and tetramers in brain and in transfectedcells. J Biol Chem 272:29229-29237
32. Okuda-Ashitaka E, Sakamoto K, Ezashi T, Miwa K, Ito S, Hayaishi O (1996): Suppression of prostaglandin Ereceptor signaling by the variant form of EP1 subtype. JBiol Chem 271:31255-31261
33. Osuga Y, Hayashi M, Kudo M, Conti M, Kobilka B, Hsueh AJ (1997): Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J Biol Chem 272:25006-25012
34. Pace AJ, Gama L, Breitwieser GE (1999): Dimerization of the calcium-sensing receptor occurs within the extracellulardomain and is eliminated by Cys -> Ser mutations atCys101 and Cys236. J Biol Chem 274:11629-11634
35. Romano C, Yang WL, O'Malley KL (1996): Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J BiolChem 271:28612-28616
36. Uphouse L (1997): Multiple serotonin receptors: Too many, not enough, or just the right number? Neurosci Biobe-hav Rev 21:679-698
37. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991): Cloning of the gene for ahuman dopamine D4 receptor with high affinity for theantipsychotic clozapine. Nature 350:610-614
38. Ward DT, Brown EM, Harris HW (1998): Disulfide bonds in the extracellular calcium-polyvalent cation-sensingreceptor correlate with dimer formation and itsresponse to divalent cations in vitro. J Biol Chem273:14476-14483
39. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, Marshall FH (1998):Heterodimerization is required for the formation of afunctional GABA(B) receptor. Nature 396:679-682
40. Xie Z, Lee SP, O'Dowd BF, George SR (1999): Serotonin 5-HT1B and 5-HT1D receptors form homodimers whenexpressed alone and heterodimers when co-expressed.FEBS Lett 456:63-67
41. Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, George SR (1998): Dopamine D2 receptor dimers inhuman and rat brain. FEBS Lett 441:383-386
42. Zeng FY, Wess J (1999): Identification and molecular charac-terization of m3 muscarinic receptor dimers. J Biol Chem 274:19487-19497
43. Zhu X, Wess J (1998): Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function.Biochemistry 37:15773-15784